Fate Share Price

Fate Share Price

NASDAQ: FATE | Micro Cap | Healthcare
$0.92
-$0.10 (-9.35%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Fate Stock Performance

Open
$1.01
Prev. Close
$1.02
Circuit Range
N/A
Day Range
$0.90 - $1.02
Year Range
$0.90 - $3.23
Volume
2,09,345
Average Traded
$0.93

Fate Share Price Today

As of 22 November 2026, Fate Therapeutics, Inc.'s share price is $0.92. The stock opened at $1.01, compared to its previous close of $1.02. During today's trading session, Fate Therapeutics, Inc.'s share price traded between $0.90 and $1.02, with an average price of $0.96. Over the past 52 weeks, the stock has recorded a high of $3.23 and a low of $0.90. In terms of performance, Fate Therapeutics, Inc.'s share price has declined by 67.44% over the last six months and is down 18.54% on a year-on-year basis.

Fate Share Price Chart

Line chart of the Fate price trend over the selected period. The price fell overall, ranging from 0.90 to 1.02, ending at 0.92.
$0.90$1.02
L
Show Current Price
H

Fate Stock Fundamentals & Key Indicators

Market Cap
$109.83M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.02
Revenue (TTM)
$6.65B
Return On Equity (TTM)
-93.54%
Profit Margin
-2049.92%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
5.19%

Fate Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.37$1.30$2.08$0.00
Net Profit-$32.37-$31.21-$30.16-$30.69
Net Profit Margin-2362.77%-2400.77%-1450.00%N/A
Income ChangeN/A3.58%3.36%-1.76%

Fate Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$96.30$63.53$13.63$6.65
Net Profit-$281.72-$160.93-$186.26-$136.32
Net Profit Margin-292.54%-253.31%-1366.54%-2049.92%
Income ChangeN/A42.88%-15.74%26.81%

Fate Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets110.23148.79174.68203.49
Current Assets208.7291.91331.54502.07
Total Assets318.94440.69506.22705.56
Non Current Liabilities75.482.9298.71107.57
Current Liabilities36.0738.5239.09114.05
Total Liabilities111.47121.44137.8221.62
Shareholders' Equity207.18318.73368.42483.94

Fate Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-106.08-122.87-132.26-248.21
Investing111.1712.22112.67166.75
Financing5.4999.890.099.21

About Fate

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Fate Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.11
$0.92
-56.08%
Oct 2026
$2.36
$2.09
-11.81%
Sep 2026
$2.38
$2.37
-6.32%
Aug 2026
$2.39
$2.53
+3.69%
Jul 2026
$2.67
$2.44
-10.13%
Jun 2026
$2.69
$2.71
-4.40%
May 2026
$1.25
$2.84
+127.20%
Apr 2026
$1.23
$1.25
+3.73%
Mar 2026
$1.44
$1.21
-18.58%
Feb 2026
$1.17
$1.48
+24.37%
Jan 2026
$1.00
$1.19
+20.93%
Dec 2025
$1.09
$0.98
-13.30%

Fate Share Price FAQs